Similarly, expression of fur- regulated IgA1 protease (Harrison et al., 2013) was required for optimal invasion and long-term intracellular survival in bronchial epithelial cells (Clementi et al., 2014)
First-line use of vepdegestrant in combination with palbociclib is also being evaluated in the Phase 3 VERITAC-3 clinical trial (NCT05909397) in patients with ER-positive, HER2-negative breast cancer who have not received prior systemic anti-cancer treatment for advanced disease
Start tracking Log your first shot, side effects, weight, body measurements, meal, and water intake
In an effort to inform solutions for optimizing GLP-1 adherence and outcomes, Omada Insights Lab published an analysis of early behaviors and outcomes of members who self-disclosed that they were taking a GLP-1 for weight loss, and opted in to Omadas Enhanced GLP-1 Care Track